Adverse drug reaction identification and extraction in social media: A scoping review

Journal of Medical Internet Research

Volumn 17, Issue 7, 2015, Pages

  Lardon, Jérémy ^a,b,c,d   Abdellaoui, Redhouane ^c,e   Bellet, Florelle ^d   Asfari, Hadyl ^a,b,c,d   Souvignet, Julien ^a,b,c,d   Texier, Nathalie ^e   Jaulent, Marie Christine ^a,b,c   Beyens, Marie Noëlle ^d   Burgun, Anita ^c,f   Bousquet, Cédric ^a,b,c,d  

^a UNIVERSITÉ PARIS 13   (France)

^b INSERM   (France)

^c INSERM   (France)

^d UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^e Kappa Sante   (France)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Adverse drug reaction; Adverse event; Internet; Pharmacovigilance; Scoping review; Social media; Text mining; Web 2.0

Indexed keywords

DRUG SURVEILLANCE PROGRAM; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMAN; INTERNET; REPRODUCIBILITY; SOCIAL MEDIA; STANDARDS; UTILIZATION;

DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; INTERNET; PHARMACOVIGILANCE; REPRODUCIBILITY OF RESULTS; SOCIAL MEDIA;

EID: 84938590261     PISSN: None     EISSN: 14388871     Source Type: Journal    
DOI: 10.2196/jmir.4304     Document Type: Review

References (66)

1. World Health Organization. Geneva, Switzerland: World Health Organization Pharmacovigilance URL: http://www.who.int/medicines/areas/quality-safety/safety-efficacy/pharmvigi/en/ [accessed 2015-06-23] [WebCite Cache ID 5zXGgxwBG]
2. World Health Organization. Geneva, Switzerland: World Health Organization English Glossary URL: http://www.who.int/medicines/areas/coordination/English-Glossary.pdf [accessed 2015-06-23] [WebCite Cache ID 6XyLFSz6M]
3. Classen DC, Resar R, Griffin F, Federico F, Frankel T, Kimmel N, et al. 'Global trigger tool' shows that adverse events in hospitals may be ten times greater than previously measured. Health Aff (Millwood) 2011 Apr;30(4):581-589 [FREE Full text] [doi: 10.1377/hlthaff.2011.0190] [Medline: 21471476]
4. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004 Jul 3;329(7456):15-19 [FREE Full text] [doi: 10.1136/bmj.329.7456.15] [Medline: 15231615]
5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998 Apr 15;279(15):1200-1205. [Medline: 9555760]
6. Mitchell AS, Henry DA, Sanson-Fisher R, O'Connell DL. Patients as a direct source of information on adverse drug reactions. BMJ 1988 Oct 8;297(6653):891-893 [FREE Full text] [Medline: 3140967]
7. Medawar C, Herxheimer A. A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine. Int J Risk Saf Med 2003;16(1):5-19.
8. van Grootheest K, de Jong-van den Berg L. Patients' role in reporting adverse drug reactions. Expert Opin Drug Saf 2004;3(4):363-368. [Medline: 15268652]
9. Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2007 Feb;63(2):148-156. [doi: 10.1111/j.1365-2125.2006.02746.x] [Medline: 17274788]
10. van Hunsel F, Talsma A, van Puijenbroek E, de Jong-van den Berg L, van Grootheest K. The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study. Pharmacoepidemiol Drug Saf 2011 Mar;20(3):286-291. [doi: 10.1002/pds.2092] [Medline: 21351310]
11. Hughes S, Cohen D. Can online consumers contribute to drug knowledge? A mixed-methods comparison of consumer-generated and professionally controlled psychotropic medication information on the internet. J Med Internet Res 2011;13(3):e53 [FREE Full text] [doi: 10.2196/jmir.1716] [Medline: 21807607]
12. Margraff F, Bertram D. Adverse drug reaction reporting by patients: an overview of fifty countries. Drug Saf 2014 Jun;37(6):409-419. [doi: 10.1007/s40264-014-0162-y] [Medline: 24748428]
13. Bates DW, Evans RS, Murff H, Stetson PD, Pizziferri L, Hripcsak G. Detecting adverse events using information technology. J Am Med Inform Assoc 2003;10(2):115-128 [FREE Full text] [Medline: 12595401]
14. Tubert P, Bégaud B, Péré JC, Haramburu F, Lellouch J. Power and weakness of spontaneous reporting: a probabilistic approach. J Clin Epidemiol 1992 Mar;45(3):283-286. [Medline: 1569425]
15. Tubert P, Bégaud B. Random models for margins of a 2 x 2 contingency table and application to pharmacovigilance. Stat Med 1991 Jun;10(6):991-999. [Medline: 1876790]
16. Chen ES, Hripcsak G, Xu H, Markatou M, Friedman C. Automated acquisition of disease drug knowledge from biomedical and clinical documents: an initial study. J Am Med Inform Assoc 2008;15(1):87-98 [FREE Full text] [doi: 10.1197/jamia.M2401] [Medline: 17947625]
17. Trifirò G, Pariente A, Coloma PM, Kors JA, Polimeni G, Miremont-Salamé G, EU-ADR group. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf 2009 Dec;18(12):1176-1184. [doi: 10.1002/pds.1836] [Medline: 19757412]
18. Aramaki E, Miura Y, Tonoike M, Ohkuma T, Masuichi H, Waki K, et al. Extraction of adverse drug effects from clinical records. Stud Health Technol Inform 2010;160(Pt 1):739-743. [Medline: 20841784]
19. Islamaj Doʇan R, Névéol A, Lu Z. A context-blocks model for identifying clinical relationships in patient records. BMC Bioinformatics 2011;12 Suppl 3:S3 [FREE Full text] [doi: 10.1186/1471-2105-12-S3-S3] [Medline: 21658290]
20. Gurulingappa H, Mateen-Rajput A, Toldo L. Extraction of potential adverse drug events from medical case reports. J Biomed Semantics 2012;3(1):15 [FREE Full text] [doi: 10.1186/2041-1480-3-15] [Medline: 23256479]
21. Warrer P, Hansen EH, Juhl-Jensen L, Aagaard L. Using text-mining techniques in electronic patient records to identify ADRs from medicine use. Br J Clin Pharmacol 2012 May;73(5):674-684. [doi: 10.1111/j.1365-2125.2011.04153.x] [Medline: 22122057]
22. Eriksson R, Jensen PB, Frankild S, Jensen LJ, Brunak S. Dictionary construction and identification of possible adverse drug events in Danish clinical narrative text. J Am Med Inform Assoc 2013;20(5):947-953 [FREE Full text] [doi: 10.1136/amiajnl-2013-001708] [Medline: 23703825]
23. Li Y, Salmasian H, Vilar S, Chase H, Friedman C, Wei Y. A method for controlling complex confounding effects in the detection of adverse drug reactions using electronic health records. J Am Med Inform Assoc 2014;21(2):308-314 [FREE Full text] [doi: 10.1136/amiajnl-2013-001718] [Medline: 23907285]
24. Micoulaud-Franchi JA. [One step more toward pharmacovigilance 2.0. Integration of web data community for a pharmacovigilance more alert] [Article in French]. Presse Med 2011 Sep;40(9 Pt 1):790-792. [doi: 10.1016/j.lpm.2011.07.001] [Medline: 21802246]
25. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005 Feb;8(1):19-32. [doi: 10.1080/1364557032000119616]
26. Levac D, Colquhoun H, O'Brien KK. Scoping studies: advancing the methodology. Implement Sci 2010;5:69 [FREE Full text] [doi: 10.1186/1748-5908-5-69] [Medline: 20854677]
27. Daudt HML, van Mossel C, Scott SJ. Enhancing the scoping study methodology: a large, inter-professional team's experience with Arksey and O'Malley's framework. BMC Med Res Methodol 2013;13:48 [FREE Full text] [doi: 10.1186/1471-2288-13-48] [Medline: 23522333]
28. Abou TM, Rossard C, Cantaloube L, Bouscaren N, Roche G, Pochard L, et al. Analysis of patients' narratives posted on social media websites on benfluorex's (Mediator®) withdrawal in France. J Clin Pharm Ther 2014 Feb;39(1):53-55. [doi: 10.1111/jcpt.12103] [Medline: 24304185]
29. Butt TF, Cox AR, Oyebode JR, Ferner RE. Internet accounts of serious adverse drug reactions: a study of experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis. Drug Saf 2012 Dec 1;35(12):1159-1170. [doi: 10.2165/11631950-000000000-00000] [Medline: 23058037]
30. Freifeld CC, Brownstein JS, Menone CM, Bao W, Filice R, Kass-Hout T, et al. Digital drug safety surveillance: monitoring pharmaceutical products in twitter. Drug Saf 2014 May;37(5):343-350 [FREE Full text] [doi: 10.1007/s40264-014-0155-x] [Medline: 24777653]
31. th Annual Meeting of Physiology, Pharmacology and Therapeutics, 22-24 April 2014, Poitiers, France [FREE Full text] [WebCite Cache]
32. Kmetz J. Visible Technologies. 2013 Dec 26. Adverse event reporting: What pharmaceutical companies need to know URL: http://www.visibletechnologies.com/blog/adverse-event-reporting-pharma/ [accessed 2015-06-23] [WebCite Cache ID 6SftTDhuQ]
33. Mao JJ, Chung A, Benton A, Hill S, Ungar L, Leonard CE, et al. Online discussion of drug side effects and discontinuation among breast cancer survivors. Pharmacoepidemiol Drug Saf 2013 Mar;22(3):256-262 [FREE Full text] [doi: 10.1002/pds.3365] [Medline: 23322591]
34. Moncrieff J, Cohen D, Mason JP. The subjective experience of taking antipsychotic medication: a content analysis of Internet data. Acta Psychiatr Scand 2009 Aug;120(2):102-111. [doi: 10.1111/j.1600-0447.2009.01356.x] [Medline: 19222405]
35. Pages A, Bondon-Guitton E, Montastruc JL, Bagheri H. Undesirable effects related to oral antineoplastic drugs: comparison between patients' internet narratives and a national pharmacovigilance database. Drug Saf 2014 Aug;37(8):629-637. [doi: 10.1007/s40264-014-0203-6] [Medline: 25027671]
36. Schröder S, Zöllner YF, Schaefer M. Drug related problems with Antiparkinsonian agents: consumer Internet reports versus published data. Pharmacoepidemiol Drug Saf 2007 Oct;16(10):1161-1166. [doi: 10.1002/pds.1415] [Medline: 17486665]
37. Vaughan Sarrazin MS, Cram P, Mazur A, Ward M, Reisinger HS. Patient perspectives of dabigatran: analysis of online discussion forums. Patient 2014;7(1):47-54. [doi: 10.1007/s40271-013-0027-y] [Medline: 24030706]
38. Benton A, Ungar L, Hill S, Hennessy S, Mao J, Chung A, et al. Identifying potential adverse effects using the web: a new approach to medical hypothesis generation. J Biomed Inform 2011 Dec;44(6):989-996 [FREE Full text] [doi: 10.1016/j.jbi.2011.07.005] [Medline: 21820083]
39. Bian J, Topaloglu U, Yu F. Towards large-scale twitter mining for drug-related adverse events. In: Proceedings of the 2012 International Workshop on Smart Health and Wellbeing (SHB '12). New York, NY: ACM; 2012 Presented at: 2012 International Workshop on Smart Health and Wellbeing (SHB '12); October 29-November 2, 2012; Maui, HI. [doi: 10.1145/2389707.2389713]
40. Hadzi-Puric J, Grmusa J. Automatic drug adverse reaction discovery from parenting websites using disproportionality methods. In: Proceedings of the 2012 International Conference on Advances in Social Networks Analysis Mining (ASONAM 2012). Washington, DC: IEEE Computer Society; 2012 Presented at: 2012 International Conference on Advances in Social Networks Analysis Mining (ASONAM 2012); August 26-29, 2012; Istanbul, Turkey. [doi: 10.1109/ASONAM.2012.144]
41. Jiang Y, Liao QV, Cheng Q, Berlin RB, Schatz BR. Designing and evaluating a clustering system for organizing and integrating patient drug outcomes in personal health messages. AMIA Annu Symp Proc 2012;2012:417-426 [FREE Full text] [Medline: 23304312]
42. Leaman R, Wojtulewicz L, Sullivan R, Skariah A, Yang J, Gonzalez G. Towards internet-age pharmacovigilance: extracting adverse drug reactions from user posts to health-related social networks. In: Proceedings of the 2010 Workshop on Biomedical Natural Language Processing (BioNLP '10). Stroudsburg, PA: ACL; 2010 Presented at: 2010 Workshop on Biomedical Natural Language Processing (BioNLP '10); July 15, 2010; Uppsala, Sweden.
43. Li YA. DSpace@MIT. Cambridge, MA: Massachusetts Institute of Technology; 2011 Feb. Medical data mining: improving information accessibility using online patient drug reviews URL: http://dspace.mit.edu/handle/1721.1/66437 [accessed 2015-06-23] [WebCite Cache ID 6Sfu51j6d]
44. Liu X, Chen H. AZDrugMiner: An information extraction system for mining patient-reported adverse drug events in online patient forums. In: Proceedings of the 2013 International Conference on Smart Health (ICSH'13). Berlin, Heidelberg, Germany: Springer; 2013 Presented at: 2013 International Conference on Smart Health (ICSH'13); August 3-4, 2013; Beijing, China. [doi: 10.1007/978-3-642-39844-5-16]
45. Nikfarjam A, Gonzalez GH. Pattern mining for extraction of mentions of Adverse Drug Reactions from user comments. AMIA Annu Symp Proc 2011;2011:1019-1026 [FREE Full text] [Medline: 22195162]
46. Sampathkumar H, Chen XW, Luo B. Mining adverse drug reactions from online healthcare forums using hidden Markov model. BMC Med Inform Decis Mak 2014;14:91 [FREE Full text] [doi: 10.1186/1472-6947-14-91] [Medline: 25341686]
47. Wu H, Fang H, Stanhope SJ. Exploiting online discussions to discover unrecognized drug side effects. Methods Inf Med 2013;52(2):152-159. [doi: 10.3414/ME12-02-0004] [Medline: 23450374]
48. Yang CC, Jiang L, Yang H, Tang X. Detecting signals of adverse drug reactions from health consumer contributed content in social media. In: Proceedings of the ACM SIGKDD Workshop on Health Informatics. New York, NY: ACM; 2012 Presented at: ACM SIGKDD Workshop on Health Informatics; August 12, 2012; Beijing, China.
49. Yates A, Goharian N, Frieder O. Extracting adverse drug reactions from forum posts linking them to drugs. In: Proceedings of the 2013 ACM SIGIR Workshop on Health Search Discovery. New York, NY: ACM; 2013 Presented at: 2013 ACM SIGIR Workshop on Health Search Discovery; August 1, 2013; Dublin, Ireland. [doi: 10.1145/2484028.2484220]
50. Yeleswarapu S, Rao A, Joseph T, Saipradeep VG, Srinivasan R. A pipeline to extract drug-adverse event pairs from multiple data sources. BMC Med Inform Decis Mak 2014;14:13 [FREE Full text] [doi: 10.1186/1472-6947-14-13] [Medline: 24559132]
51. Consumer Health Vocabulary Initiative. URL: http://www.consumerhealthvocab.org/ [accessed 2015-06-23] [WebCite Cache ID 6Sfy1bTCY]
52. th European Conference on Advances in Information Retrieval (ECIR'13); March 24-27, 2013; Moscow, Russia p. 24-27. [doi: 10.1007/978-3-642-36973-5-92]
53. MetaMap. URL: http://metamap.nlm.nih.gov/ [accessed 2015-06-23] [WebCite Cache ID 6SfyBf7Xq]
54. US Food and Drug Administration. Silver Spring, MD: US FDA FDA Adverse Event Reporting System (FAERS) URL: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm [accessed 2014-09-18] [WebCite Cache ID 6Sfxrss3N]
55. Harris JK, Mansour R, Choucair B, Olson J, Nissen C, Bhatt J, Centers for Disease Control and Prevention. Health department use of social media to identify foodborne illness - Chicago, Illinois, 2013-2014. MMWR Morb Mortal Wkly Rep 2014 Aug 15;63(32):681-685 [FREE Full text] [Medline: 25121710]
56. Kuehn BM. Agencies use social media to track foodborne illness. JAMA 2014 Jul;312(2):117-118. [doi: 10.1001/jama.2014.7731] [Medline: 24963655]
57. Chapman B, Raymond B, Powell D. Potential of social media as a tool to combat foodborne illness. Perspect Public Health 2014 Jul;134(4):225-230. [doi: 10.1177/1757913914538015] [Medline: 24990140]
58. Edwards IR, Lindquist M, Wiholm BE, Napke E. Quality criteria for early signals of possible adverse drug reactions. Lancet 1990 Jul 21;336(8708):156-158. [Medline: 1973481]
59. Franzen W. Can social media benefit drug safety? Drug Saf 2011 Sep 1;34(9):793. [doi: 10.2165/11595510-000000000-00000] [Medline: 21830842]
60. Smith CA, Wicks PJ. PatientsLikeMe: Consumer health vocabulary as a folksonomy. AMIA Annu Symp Proc 2008:682-686 [FREE Full text] [Medline: 18999004]
61. Zeng Q, Kogan S, Ash N, Greenes RA, Boxwala AA. Characteristics of consumer terminology for health information retrieval. Methods Inf Med 2002;41(4):289-298. [Medline: 12425240]
62. Hanson CL, Cannon B, Burton S, Giraud-Carrier C. An exploration of social circles and prescription drug abuse through Twitter. J Med Internet Res 2013;15(9):e189 [FREE Full text] [doi: 10.2196/jmir.2741] [Medline: 24014109]
63. Hanson CL, Burton SH, Giraud-Carrier C, West JH, Barnes MD, Hansen B. Tweaking and tweeting: exploring Twitter for nonmedical use of a psychostimulant drug (Adderall) among college students. J Med Internet Res 2013;15(4):e62 [FREE Full text] [doi: 10.2196/jmir.2503] [Medline: 23594933]
64. Härmark L, van Puijenbroek E, van Grootheest K. Intensive monitoring of duloxetine: results of a web-based intensive monitoring study. Eur J Clin Pharmacol 2013 Feb;69(2):209-215 [FREE Full text] [doi: 10.1007/s00228-012-1313-7] [Medline: 22688722]
65. Gottlieb A, Hoehndorf R, Dumontier M, Altman RB. Ranking adverse drug reactions with crowdsourcing. J Med Internet Res 2015;17(3):e80 [FREE Full text] [doi: 10.2196/jmir.3962] [Medline: 25800813]
66. Yom-Tov E, Gabrilovich E. Postmarket drug surveillance without trial costs: discovery of adverse drug reactions through large-scale analysis of web search queries. J Med Internet Res 2013;15(6):e124 [FREE Full text] [doi: 10.2196/jmir.2614] [Medline: 23778053]